Chronic Kidney Disease and RAAS Blockade: A New view of Renoprotection

Chronic Kidney Disease and RAAS Blockade: A New view of Renoprotection


Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days

₹ 5,886

Availability: Out of stock


Delivery :

5% Cashback on all Orders paid using MobiKwik Wallet T&C

Free Krispy Kreme Voucher on all Orders paid using UltraCash Wallet T&C
Product Out of Stock Subscription

(Notify me when this product is back in stock)

  • Product Description

Despite an increasing use of ACE inhibitors (ACEIs) and angiotensin receptor blockers (ARB) by tens of millions of chronic kidney disease (CKD) patients around the world for reno-protection, we have continued to witness global pandemics of acute renal failure, CKD and end-stage renal disease. While the mechanisms for these global pandemics remain speculative, there is accruing evidence of iatrogenic renal failure from ACEIs and ARBs. Since 2005, we have published an increasing number of such reports from our center. More complimentary reports from around the world have surfaced in recent years. We described two new syndromes - late onset renal failure from angiotensin blockade (LORFFAB) and the syndrome of rapid onset end-stage renal disease (SORO-ESRD). This book is an amalgam of all our work with new unpublished data. The contributions of LORFFAB and SORO-ESRD to the global pandemics warrant worldwide study. Finally, this work presents a very balanced review of the evidence base for reno-protection with ACEIs and ARBs and should be especially useful to medical professionals in Family Medicine, Internal Medicine, Nephrology and Hypertension, Emergency Medicine and Cardiology.

Product Specifications
SKU :COC94629
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-08-14
0 Review(s)